Tremfya 100 MG/ML one-pressml
Ended Awarded Last action
- Contract number
- SPE2DR26F7UV0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,795
Award facts
- Contract value 100% obligated
- $48,795.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $48,795.47 delivery order from the Defense Logistics Agency (DLA) on January 2, 2026, for TREMFYA 100 mg/ml (guselkumab), a prescription medication used to treat plaque psoriasis and other inflammatory conditions. This competitively awarded, firm fixed-price contract is scheduled for completion by January 5, 2026, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. No set-aside designation was applied to this award, indicating open competition among qualified vendors.
This delivery order is issued under AmerisourceBergen's significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products, specialty medications, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare system customers worldwide. The award reflects the company's established capability to meet federal procurement requirements for critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F7UV0?
SPE2DR26F7UV0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F7UV0 worth?
The government has obligated $48,795 on SPE2DR26F7UV0.
Is contract SPE2DR26F7UV0 an order under another contract?
Yes. SPE2DR26F7UV0 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UV0 competed?
The extent of competition for SPE2DR26F7UV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award